Law360 (November 2, 2018, 6:08 PM EDT) -- Metuchen Pharmaceuticals LLC's patent case against a company accused of selling a knockoff of the erectile dysfunction drug Stendra is headed to Texas after a judge decided Thursday the defendant's pharmaceutical license in New Jersey didn't give it a place of business in the state.
Chief Judge Jose Linares in the District of New Jersey ordered the lawsuit be transferred to the Southern District of Texas, where defendant Empower Pharmaceuticals LLC is based. The judge said Empower being licensed in New Jersey as an out-of-state pharmacy didn't provide a basis for keeping the case there.
"Defendants' status as one of the...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!